L. L. Shelly, K. J. Lei, C. J. Pan, S. F. Sakata, S. Ruppert et al., Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A, J. Biol. Chem, vol.268, pp.21482-21485, 1993.

R. Froissart, M. Piraud, A. M. Boudjemline, C. Vianey-saban, F. Petit et al., Glucose-6-phosphatase deficiency, Orphanet J. Rare Dis, vol.6, p.27, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00668423

F. Rajas, J. Clar, A. Gautier-stein, and G. Mithieux, Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease, J. Inherit. Metab. Dis, vol.38, pp.521-527, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01350960

J. Y. Chou, H. S. Jun, and B. C. Mansfield, Glycogen storage disease type I and G6Pase-b deficiency: etiology and therapy, Nat. Rev. Endocrinol, vol.6, pp.676-688, 2010.

N. Bruni, F. Rajas, S. Montano, F. Chevalier-porst, I. Maire et al., Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a, Ann. Hum. Genet, vol.63, pp.141-146, 1999.

J. Y. Chou, D. Matern, B. C. Mansfield, C. , and Y. T. , Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex, Curr. Mol. Med, vol.2, pp.121-143, 2002.

J. P. Rake, G. Visser, P. Labrune, J. V. Leonard, K. Ullrich et al., Guidelines for management of glycogen storage disease type I-European Study on Glycogen Storage Disease Type I (ESGSD I), Eur. J. Pediatr, vol.161, issue.1, pp.112-119

J. Clar, E. Mutel, B. Gri, A. Creneguy, A. Stefanutti et al., Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice, Hum. Mol. Genet, vol.24, pp.2287-2296, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01350897

D. D. Koeberl, B. Sun, A. Bird, Y. T. Chen, K. Oka et al., Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia, Mol. Ther, vol.15, pp.1253-1258, 2007.

Y. M. Lee, G. Y. Kim, C. J. Pan, B. C. Mansfield, and J. Y. Chou, Minimal hepatic glucose-6-phosphatase-a activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia, Mol. Genet. Metab. Rep, vol.3, pp.28-32, 2015.

D. Q. Wang, L. M. Fiske, C. T. Carreras, and D. A. Weinstein, GFP mRNA-treated WT mice (red circles), GFP mRNA-treated L.G6PC À/À mice (green circles), G6PC-WT-treated L.G6PC À/À mice (purple circles), G6PC-V1-treated L.G6PC À/À mice (orange circles), and G6PC-V2-treated L.G6PC À/À mice (black circles). Data were obtained from mice fasted for 24 hr, and individual treatment groups (n = 5 or 6) are shown, with bars representing the mean ± 95% CI. The groups were compared by one-way ANOVA, J. Pediatr, vol.159, pp.442-446, 2011.

L. M. Franco, V. Krishnamurthy, D. Bali, D. A. Weinstein, P. Arn et al., Hepatocellular carcinoma in glycogen storage disease type Ia: a case series, J. Inherit. Metab. Dis, vol.28, pp.153-162, 2005.

J. Calderaro, P. Labrune, G. Morcrette, S. Rebouissou, D. Franco et al., Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I, J. Hepatol, vol.58, pp.350-357, 2013.

A. Zingone, H. Hiraiwa, C. J. Pan, B. Lin, H. Chen et al., Correction of glycogen storage disease type 1a in a mouse model by gene therapy, J. Biol. Chem, vol.275, pp.828-832, 2000.

G. Y. Kim, Y. M. Lee, J. H. Kwon, J. H. Cho, C. J. Pan et al., Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-a activity restored are at risk of developing hepatic tumors, Mol. Genet. Metab, vol.120, pp.229-234, 2017.

D. A. Weinstein, C. E. Correia, T. Conlon, A. Specht, J. Verstegen et al., Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia. Hum, Gene Ther, vol.21, pp.903-910, 2010.

B. Crane, X. Luo, A. Demaster, K. D. Williams, D. M. Kozink et al., Rescue administration of a helperdependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia, Gene Ther, vol.19, pp.443-452, 2012.

A. Demaster, X. Luo, S. Curtis, K. D. Williams, D. J. Landau et al., Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type Ia, Hum. Gene Ther, vol.23, pp.407-418, 2012.

E. D. Brooks, D. Little, R. Arumugam, B. Sun, S. Curtis et al., , 2013.

, Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia, Mol. Genet. Metab, vol.109, pp.161-170

S. Hareendran, B. Balakrishnan, D. Sen, S. Kumar, A. Srivastava et al., Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them, Rev. Med. Virol, vol.23, pp.399-413, 2013.

L. Zangi, K. O. Lui, A. Von-gise, Q. Ma, W. Ebina et al., Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction, Nat. Biotechnol, vol.31, pp.898-907, 2013.

L. Sun, Y. Xiong, A. Bashan, E. Zimmerman, S. Shulman-daube et al., A recombinant collagen-mRNA platform for controllable protein synthesis, ChemBioChem, vol.16, pp.1415-1419, 2015.

E. Mutel, A. Abdul-wahed, N. Ramamonjisoa, A. Stefanutti, I. Houberdon et al., Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J. Hepatol, vol.54, pp.529-537, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00575314

S. J. Boers, G. Visser, P. G. Smit, and S. A. Fuchs, Liver transplantation in glycogen storage disease type I, Orphanet J. Rare Dis, vol.9, p.47, 2014.

K. J. Lei, H. Chen, C. J. Pan, J. M. Ward, B. Mosinger et al., Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse, Nat. Genet, vol.13, pp.203-209, 1996.

H. H. Taussky and E. Shorr, A microcolorimetric method for the determination of inorganic phosphorus, J. Biol. Chem, vol.202, pp.675-685, 1953.